Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...

If you happen to have some leftover mash or pick up a pack from the reduced section of the supermarket, these crispy, cheesy potato cakes are the perfect thing to make! Each potato cake provides 138 ...